Abstract
Background
Psychological stress is associated with reduced blood pressure (BP) dipping, but the underlying mechanisms are unclear. This study examined the associations among stress‐induced sodium excretion, diurnal sodium excretion, and BP dipping.
Methods
Apparently healthy adult participants underwent a laboratory session during which urinary sodium excretion was measured before and after mental stress tasks. Participants then completed 24‐hour ambulatory BP monitoring and separate awake and asleep urine collections. The change in urinary sodium excretion rate with stress was defined as the difference in urinary sodium excretion rate before and after stress. The awake‐to‐asleep ratio of the urinary sodium excretion rate and systolic BP dipping were calculated from the 24‐hour urine and BP measurements.
Results
In an adjusted model including age, sex, race, ethnicity, body mass index, mean systolic BP, mean diastolic BP, parental history of hypertension, fasting glucose, and 24‐hour creatinine clearance, a smaller stress‐induced urinary sodium excretion rate was associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate (n=180, B=0.2253 [95% CI, 0.0490–0.4016]). In an adjusted model including age, sex, race, ethnicity, body mass index, current smoking, alcohol use, fasting glucose, 24‐hour sodium excretion, 24‐hour potassium excretion, 24‐hour creatinine clearance, and fractional excretion of sodium, a lower awake‐to‐asleep ratio of the urinary sodium excretion rate was associated with lower systolic BP dipping (n=175, B=1.0127 [95% CI, 0.0599–1.9656]).
Conclusions
A lower stress‐induced urinary sodium excretion rate was associated with a worse diurnal pattern of urinary sodium excretion, which was associated with lower systolic BP dipping.
Registration Information
clinicaltrials.gov. Identifier: NCT03636490.
Keywords: blood pressure, diurnal, psychological stress, sodium excretion
Subject Categories: Translational Studies, Pathophysiology
Nonstandard Abbreviations and Acronyms
- ABPM
ambulatory blood pressure monitoring
- EMA
ecological momentary assessment
- SABRE
Stress, Salt Excretion, and Nighttime Blood Pressure
- VAS
Visual Analog Scale
Research Perspective.
What Is New?
Psychological stress is associated with reduced blood pressure dipping, which predicts future cardiovascular disease events; however, the mechanisms underlying the link between stress and lower blood pressure dipping are unclear.
The current study examined whether there is an association between urinary sodium excretion induced by psychological stress and its diurnal pattern, and whether the diurnal pattern of sodium excretion is associated with blood pressure dipping.
What Question Should Be Addressed Next?
How stress‐induced sodium excretion, the diurnal pattern of sodium excretion, and blood pressure dipping are biologically linked.
Normally, blood pressure (BP) follows a diurnal rhythm, in which it is highest during the daytime while awake and falls to its lowest level during the nighttime while asleep, a phenomenon called BP dipping. 1 , 2 The variation of BP over 24 hours can be assessed using ambulatory BP monitoring (ABPM). 1 , 3 On ABPM, reduced BP dipping is associated with an increased risk of cardiovascular disease (CVD) events. 4 , 5 A meta‐analysis indicated that among individuals from population‐based samples, the adjusted hazard ratio of incident CVD events associated with a nondipping BP pattern (<10% reduction in average nighttime systolic BP [SBP] compared with average daytime SBP) was 2.05 (95% CI, 1.00–4.20). 5 We and others have shown that a nondipping BP pattern is highly prevalent (31%–64%) among both population and community samples. 6 , 7 , 8 , 9
Evidence suggests that psychological stress is associated with reduced BP dipping. 8 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 Sleep disturbances have been proposed to be the primary mechanism underlying the link between psychological stress and reduced BP dipping. 16 , 18 , 19 However, another possible mechanism is the disruption of the diurnal pattern of urinary sodium excretion. Similar to BP, urinary sodium excretion typically peaks during the day and dips during the night. 20 The normal physiological response to increased dietary sodium intake during the day is BP elevation, which itself leads to increased urinary sodium excretion and maintenance of sodium homeostasis. 20 , 21 It has been hypothesized that when urinary sodium excretion does not occur normally during the daytime, sodium excretion continues during the nighttime period, resulting in a lower awake‐to‐asleep urinary sodium excretion ratio. 20 , 21 , 22 This change in diurnal sodium excretion may be accompanied by an increase in nighttime BP, which results in nondipping BP, and facilitates sodium excretion via increased renal perfusion pressure. 20 , 21 , 22 Several studies have demonstrated an association between an abnormal diurnal pattern of sodium excretion and an abnormal diurnal pattern of BP. 20 , 22 , 23 , 24
Exposure to an acute psychological stressor normally increases urinary sodium excretion through pressure natriuresis. 25 , 26 , 27 However, there is substantial between‐person variability in stress‐induced sodium excretion; some individuals exhibit reduced sodium excretion following stress provocation, despite an increase in BP. 28 , 29 , 30 It is plausible that a smaller stress‐induced sodium excretion reflects a diminished capacity to excrete sodium during periods of psychological stress while awake. Such an impairment could contribute to a less favorable diurnal pattern of sodium excretion. In turn, this pattern may be associated with lower BP dipping. However, there are scarce data to support this mechanistic model.
The goal of the SABRE (Stress, Salt Excretion, and Nighttime Blood Pressure) study was to examine whether urinary sodium excretion induced by psychological stress and its diurnal pattern is a mechanism that underlies reduced BP dipping. 31 We tested 2 primary hypotheses (Figure 1): A lower change in urinary sodium excretion rate with stress in the laboratory is associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate over a 24‐hour period (hypothesis 1), and a lower ratio of awake‐to‐asleep urinary sodium excretion rate is associated with lower BP dipping over a 24‐hour period (hypothesis 2). In a secondary analysis, we also examined whether the association between the urinary sodium excretion rate with stress and awake‐to‐asleep ratio of urinary sodium excretion rate is modified by higher ecological levels of stress.
Figure 1. Conceptual model.

Black arrows represent primary hypotheses. Blue arrow represents a secondary analysis, and the plus sign represents a statistical interaction. Hypothesis 1 (H1): A lower change in urinary sodium excretion rate with stress in the laboratory is associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate over a 24‐hour period. Hypothesis 2 (H2): A lower ratio of awake‐to‐asleep urinary sodium excretion rate is associated with lower BP dipping over the same 24‐hour period. Secondary analysis: Whether the association between the urinary sodium excretion rate with stress and awake‐to‐asleep ratio of urinary sodium excretion rate is modified by higher ecological levels of stress. BP indicates blood pressure.
METHODS
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Sample Population
Enrollment into the National Institutes of Health–funded SABRE study occurred between November 2018 and September 2023. 31 Potential participants were recruited through word of mouth, targeted campus‐wide emails and newsletters, social media, study flyers placed in the racially and ethnically diverse Washington Heights neighborhood in northern Manhattan, including at Columbia University Irving Medical Center, as well as through RecruitMe, a web‐based registry for potential research participants in the New York City area. The study included adults aged ≥21 years who had a mean screening SBP <160 mm Hg and diastolic BP (DBP) <105 mm Hg. Exclusion criteria included a history of overt CVD (coronary heart disease, heart failure, stroke, peripheral artery disease, permanent or recurring arrhythmias); history of secondary hypertension, diabetes, or dyslipidemia; currently taking antihypertensive medication or other medications that are known to substantially affect BP (eg, steroids, chronic anti‐inflammatory medications); red–green color blindness, as the study included the Stroop Color Test to induce psychological stress; shift or night workers; food allergies or intolerances to nuts, soy, milk, wheat, or gluten, as well as those adhering to specialized diets (eg, ketogenic, vegan), as the study‐provided foods did not adhere to these specialized dietary restrictions; non‐English speaker; involvement in another concurrent study; chronic insomnia as determined by the Insomnia Symptom Questionnaire, which was modified to align with the International Classification of Sleep Disorders, Third Edition (ICSD‐3) criteria 32 ; and moderate to severe sleep apnea, defined by an Apnea–Hypopnea Index ≥15 events/h, and assessed using the ApneaLink Air device (ResMed Corporation, San Diego, CA), a type III home sleep apnea test device. The protocol of the SABRE study was approved by the Institutional Review Board at Columbia University, and all participants provided written informed consent (ClinicalTrials.gov number: NCT03636490).
A Strengthening the Reporting of Observational Studies in Epidemiology diagram is provided in Figure S1. Briefly, 2255 individuals were recruited and invited to complete an initial screening questionnaire, of whom 1324 completed screening. Following eligibility assessment, in‐person screening, and home sleep testing, 323 participants met all study eligibility criteria and 263 initiated the controlled dietary protocol. Of these, 257 completed both the laboratory and ambulatory sessions. Among the 257 participants, 77 were excluded from the hypothesis 1 analysis because of missing urinary sodium excretion measures (ie, missing change in urinary sodium excretion rate with stress or awake‐to‐asleep ratio of urinary sodium excretion rate) or covariates (n=18), or lack of high‐quality urine collection (defined below, n=59), yielding an analytical sample of 180 participants. For hypothesis 2, 82 participants were excluded because of missing awake‐to‐asleep ratio of urinary sodium excretion rate, incomplete ABPM data, missing SBP dipping values (n=25), or lack of high‐quality urine collection (n=57), yielding an analytical sample of 175 participants.
Study Procedures
Screening Visit
The online data supplement provides details on the screening procedures (Data S1). Initial eligibility was determined using online questionnaires and research staff–administered BP measurement. Anthropometric measures including height, weight, and waist circumference were measured in‐person before undergoing home sleep testing. Final eligibility was determined after home sleep testing for assessment of sleep apnea, and enrolled participants completed online questionnaires via Qualtrics assessing sociodemographic, behavioral, psychological trait, and chronic stress factors. For the 3 days before the laboratory session, participants followed a controlled diet standardized to 4000 mg of sodium (165 mmol) and 2700 mg of potassium (72 mmol) per day, levels reflective of typical US adult intake. 33 , 34 Isocaloric, micronutrient‐controlled meals were prepared by the Human Nutrition Research Core at Columbia University Irving Medical Center. Participants were instructed to consume only study‐provided foods at home, with adherence monitored through regular staff contact. Diets were routinely verified through third‐party chemical analysis by Covance Laboratories (Madison, WI; now Eurofins Scientific).
Laboratory Session
Participants were asked to fast and not exercise for 12 hours before the laboratory session, as well as to not consume any liquids after midnight. Upon arrival, participants were asked to empty their bladder and fitted with an appropriate‐sized cuff on the nondominant arm connected to a validated SpaceLabs 90227 ABPM device (SpaceLabs, Snoqualmie, WA), which was programmed to measure BP every 5 minutes (Figure 2). 35 Participants were instructed to ingest 200 mL of water and then sit with the nondominant arm and back supported, legs uncrossed, and feet flat on the floor while watching a standardized relaxing video during a 30‐minute rest period. Participants were not allowed to talk, use their phone, read, or sleep. At the end of this resting baseline period (time point 1), a Visual Analog Scale (VAS) (0=not at all, 5=moderately, and 10=extremely) was used to assess psychological stress level. The VAS stress ratings were used during the study to ensure that the mental stress tasks were having their intended effects. A blood sample and a urine sample from a complete void of the bladder were collected.
Figure 2. Laboratory session and ambulatory session timelines.

BP indicates blood pressure; EMA, ecological momentary assessment; HR, heart rate; and VAS, Visual Analog Scale.
Participants ingested an additional 200 mL of water and underwent a 10‐minute mental stress induction protocol in the seated position, consisting of a 5‐minute computer‐administered Stroop Color Test, followed by a 5‐minute trained staff–administered verbal Mental Arithmetic Task. At the end of the stress period (time point 2), the VAS stress rating and urine sample collection from a complete void were repeated. Finally, participants ingested another 200 mL of water and were seated during a 30‐minute recovery period during which they were not allowed to talk, use their phone, read, or sleep. Following the recovery period (time point 3), a VAS stress rating and a urine sample from a complete void were collected.
At time point 1, the blood samples were used to measure sodium, potassium, chloride, creatinine, a lipid panel, fasting glucose, and hemoglobin A1c, and the urine samples were used to analyze albumin‐to‐creatinine ratio. Urine samples were analyzed for sodium (primary measure for the hypotheses), potassium, chloride, and creatinine.
Ambulatory Session
Following the laboratory session, participants were fitted with another SpaceLabs ABPM device, using the same cuff size and arm, which was programmed to measure BP every 30 minutes throughout the subsequent 24‐hour period. Participants were instructed on how to wear the ABPM device during the monitoring period and were asked to complete an ABPM device log (ie, a diary) to self‐report asleep and awake times and periods of device removal, which we have previously shown to have high agreement with actigraphy. 36 Participants were instructed to resume their usual diets but to limit alcohol intake. Participants were given 2 containers to separately collect all urine voided during the awake and asleep periods, respectively. Participants were instructed to urinate into the awake container for the last void before going to bed, and the asleep container for all voids during the middle of the night, and the first void upon waking the following morning. After leaving the laboratory, 5 ecological momentary assessment (EMA) ratings of perceived stress and negative affect (angry/hostile, aggravated/irritated, anxious/tense/nervous, and sad/blue/depressed) were collected at random time points during the awake period using SMS‐text messaged Qualtrics survey links. The EMA ratings were sent at least 1 hour after the laboratory session, 1 hour before the expected sleep time, and 1 hour after the previous EMA rating. For each EMA rating (0=not at all, 5=moderately, and 10=extremely), the participant was asked to immediately rate the following: “How stressed do you feel at this moment?” The participant also rated specific components of negative affect: “How angry/hostile do you feel at this moment? How aggravated/irritated do you feel at this moment? How anxious/tense/nervous do you feel at this moment? How sad/blue/depressed do you feel at this moment?” After completing the ambulatory session, participants returned the next morning, and the ABPM device and BP cuff were removed. The volume of urine was measured in the awake and asleep collection containers, and participants were interviewed about the duration of the urine collection and if any errors in collection occurred (eg, missing the collection of any voids, urinating into the wrong container). Based on prior studies, a high‐quality urine collection in the ambulatory session was defined as a 24‐hour urine volume ≥500 mL, a urine collection duration of ≥22 hours, and no reported missed voids or use of the wrong container. 37 , 38 , 39 , 40 , 41
Study Measures
Change in Urinary Sodium Excretion Rate With Stress in the Laboratory
Resting baseline urinary sodium excretion rate at time point 1 (uEq/min) and stress urinary sodium excretion rate at time point 2 (uEq/min) were calculated by multiplying urinary sodium concentration (uEq/mL) by urinary flow rate (mL/min) at each time point. 29 , 42 , 43 As previously described, the change in urinary sodium excretion rate with stress (uEq/min) was calculated as the difference between stress urinary sodium excretion rate at time point 2 and resting baseline urinary sodium excretion rate at time point 1. 29 , 42 , 43 This approach allows for each participant's resting baseline urinary sodium excretion rate to serve as a nonstress control. A complete urine collection in the laboratory session was defined as having valid data for both resting baseline urinary sodium excretion rate at time point 1 and stress urinary sodium excretion rate at time point 2.
Awake‐to‐Asleep Ratio of Urinary Sodium Excretion Rate Over a 24‐Hour Period
Awake urinary sodium excretion rate (uEq/min) and asleep urinary sodium excretion rate (uEq/min) were calculated by multiplying urinary sodium concentration (uEq/mL) by urinary flow rate (mL/min) for each period. 22 Awake‐to‐asleep urinary sodium excretion rate ratio (unitless) was selected a priori to characterize the relative diurnal distribution of sodium excretion, and was calculated as the ratio of awake urinary sodium excretion rate to asleep urinary sodium excretion rate. 22
BP Dipping Over a 24‐Hour Period
Using the ABPM device log, each BP reading on ABPM was classified as awake or asleep. Mean awake and mean asleep SBP and DBP were calculated by averaging the BP readings during the awake and asleep periods, respectively. BP dipping was selected a priori to characterize the relative nocturnal decline in BP. SBP dipping (percentage) was calculated as 100 × (mean awake minus mean asleep SBP) / (mean awake SBP). 1 DBP dipping (percentage) was calculated similarly using mean awake DBP and mean asleep DBP. 1 Given the stronger association of SBP versus DBP dipping with CVD, SBP dipping was used as a primary measure and DBP dipping as a secondary measure. 4 , 5 No consensus exists on the number of BP readings required during awake and asleep periods to designate an ABPM as complete. 1 As we have done in our prior studies, a complete ABPM period was defined a priori as ≥14 valid BP readings while awake, and ≥6 valid BP readings while asleep. 44 , 45 This number of valid readings has previously been shown to have sufficient reliability and accuracy for predicting CVD events. 46
EMA Ratings of Perceived Stress and Negative Affect
The ecological stress level for the awake period, during which participants' sodium excretion was measured, was defined as the average of perceived stress level across the 5 EMA ratings. The 5 EMA ratings of negative affect (angry/hostile, aggravated/irritated, anxious/tense/nervous, and sad/blue/depressed) were also averaged separately for each affect. Having complete EMA ratings was defined as having ≥3 of the 5 ratings.
Additional Measures Using the Urine Collected During the Ambulatory Session
Twenty‐four‐hour sodium excretion (uEq/24 hours) was calculated by adding awake urinary sodium excretion rate (uEq/mL) × urine volume during awake period (mL) to asleep urinary sodium excretion rate (uEq/mL) × urine volume during the asleep period (mL). Urinary potassium and creatinine were also measured using samples from the awake and asleep periods and used to calculate 24‐hour potassium excretion (uEq/24 hours) and 24‐hour creatinine clearance (mL/min). Fractional excretion of sodium was calculated as (urinary sodium concentration × urinary flow rate) /(serum sodium × creatinine clearance).
Statistical Analysis
Participant characteristics (N=180) are summarized using mean±SD for continuous variables, and frequencies and percentages for categorical variables. As a manipulation check of the mental stress tasks, we assessed the pre‐ and posttask changes in VAS stress ratings, SBP, and DBP during the laboratory session.
Power calculations for hypotheses 1 and 2 are provided in Data S1. To address hypothesis 1 (N=180), that the change in urinary sodium excretion rate with stress in the laboratory is associated with the awake‐to‐asleep ratio of urinary sodium excretion rate over a 24‐hour period, linear regression analysis was used to estimate unadjusted and covariate‐adjusted models. Unstandardized regression coefficients (B) were rescaled to represent the change in the outcome associated with a 1‐SD change in the predictor; 95% CIs are also reported. A positive B regression coefficient is interpreted as a greater increase in urinary sodium excretion rate with stress in the laboratory is associated with a higher awake‐to‐asleep ratio of urinary sodium excretion over a 24‐hour period, or alternatively, a smaller change in urinary sodium excretion rate with stress in the laboratory is associated with a lower awake‐to‐asleep ratio of urinary sodium excretion over a 24‐hour period. We selected the following covariates for adjustment in the multiple regression model: age, sex, race, and ethnicity (non‐Hispanic White, non‐Hispanic Black, Hispanic, and other), body mass index (BMI), mean SBP during the baseline period, mean DBP during the baseline period, parental history of hypertension, fasting glucose, and 24‐hour creatinine clearance. Age, sex, and race and ethnicity are standard covariates in studies of hypertension, given their well‐known associations with BP. 47 BMI was included as a covariate since it is associated with both a lower change in urinary sodium excretion rate with stress and a lower awake‐to‐asleep ratio of urinary sodium excretion rate. 22 , 43 , 48 Prior data have indicated that higher clinic SBP, higher clinic DBP, and parental history of hypertension are associated with a lower change in urinary sodium excretion rate with stress. 49 , 50 Further, higher fasting blood glucose and lower 24‐hour creatinine clearance are each associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate. 22 Paired sample t‐tests were conducted to determine if there was a difference in VAS stress ratings, BP, and heart rate before and after the mental stress tasks. In secondary analyses, we also examined whether the association between urinary sodium excretion rate with stress in the laboratory and awake‐to‐asleep ratio of urinary sodium excretion over a 24‐hour period was modified by EMA ratings of perceived stress among the subset (N=175) of the 180 participants with complete EMA ratings of perceived stress and negative affect. Controlling for each EMA rating and change in urinary sodium excretion rate with stress, we tested their multiplicative interaction term in a fully adjusted model. A positive interaction effect suggests that the association between urinary sodium excretion rate with stress in the laboratory and awake‐to‐asleep ratio of urinary sodium excretion over a 24‐hour period is stronger among those who experience higher stress during the awake period of monitoring. The analyses were repeated for each EMA rating of negative affect.
To address hypothesis 2 (N=175), that the awake‐to‐asleep ratio of urinary sodium excretion rate is associated with SBP dipping over a 24‐hour period, standard regression analysis was used again to estimate unadjusted and adjusted models. The covariates that were included in adjusted models are age, sex, race, ethnicity, BMI, current smoking status, alcohol use (none, moderate, heavy), fasting blood glucose, 24‐hour sodium excretion, 24‐hour potassium excretion, 24‐hour creatinine clearance, and fractional excretion of sodium. In addition to age, sex, race, and ethnicity, the other measures were chosen as covariates because prior studies indicate they may confound the association between the diurnal pattern of sodium excretion and the diurnal pattern of BP. 22 , 51 These analyses were repeated by replacing SBP dipping with DBP dipping.
Several exploratory analyses were conducted including examination of (1) sex as a moderator of the associations specified in hypotheses 1 and 2, given potential sex differences in stress‐induced sodium excretion; 43 , 52 (2) the associations of BP reactivity (ie, change from baseline to peak BP with the mental stress tasks) with awake‐to‐asleep ratio of urinary sodium excretion rate, and separately BP dipping; (3) the associations of the change in urinary sodium excretion rate with stress with awake urinary sodium excretion rate, and separately asleep urinary sodium excretion rate; and (4) whether the association of awake‐to‐asleep ratio of urinary sodium excretion rate with BP dipping was modified by EMA ratings of perceived stress or the change in urinary sodium excretion rate with stress. We also examined (5) the association between the change in urinary sodium excretion rate with stress and BP dipping and whether awake‐to‐asleep ratio of urinary sodium excretion rate partially explained this association.
A 2‐tailed P value of <0.05 was considered statistically significant. All analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC).
RESULTS
Baseline Characteristics
Among the 180 participants, the mean age was 32.5±10.7 years; 62.2% women; 42.2% White, 12.2% Black or African American, 27.8% Asian, 1.1% American Indian/Alaska Native, 13.9% >1 race; 21.1% were Hispanic; and 37.2% had a parental history of hypertension (Table 1). The mean BMI was 24.2±4.4 kg/m2.
Table 1.
Baseline Characteristics
| N=180 | |
|---|---|
| Age, y, mean±SD | 32.5±10.7 |
| Sex, n (%) | |
| Male | 67 (37.2) |
| Female | 112 (62.2) |
| Prefer not to answer | 1 (0.6) |
| Race, n (%) | |
| White | 76 (42.2) |
| Black or African American | 22 (12.2) |
| Asian | 50 (27.8) |
| American Indian/Alaska Native | 2 (1.1) |
| >1 race | 25 (13.9) |
| Unknown or not reported | 5 (2.8) |
| Ethnicity, n (%) | |
| Hispanic or Latino | 38 (21.1) |
| Not Hispanic or Latino | 142 (78.9) |
| Current smoking, n (%) | 5 (2.8) |
| Alcohol use, n (%) | |
| None | 71 (39.4) |
| Moderate | 106 (58.9) |
| Heavy | 3 (1.7) |
| Parental history of hypertension, n (%) | 67 (37.2) |
| Body mass index, kg/m2, mean±SD | 24.2±4.4 |
| SBP during the baseline period, mm Hg, mean±SD | 111.0±10.5 |
| DBP during the baseline period, mm Hg, mean±SD | 72.2±6.9 |
| Fasting glucose, mg/dL, mean±SD | 89.2±7.0 |
| 24‐hour sodium excretion, mmol/24‐hour, mean±SD | 121.7±51.7 |
| 24‐hour potassium excretion, mmol/24‐hour, mean±SD | 53.8±22.9 |
| 24‐hour creatinine clearance, mL/min, mean±SD | 112.7±34.1 |
| Fractional excretion of sodium, %, mean±SD | 0.54±0.19 |
| EMA ratings of perceived stress, unitless, mean±SD | 1.5±1.5 |
| EMA ratings of angry/hostile, unitless, mean±SD | 0.5±1.0 |
| EMA ratings of aggravated/irritated, unitless, mean±SD | 0.8±1.2 |
| EMA ratings of anxious/tense/nervous, unitless, mean±SD | 1.1±1.4 |
| EMA ratings of sad/blue/depressed, unitless, mean±SD | 0.6±1.1 |
| Baseline urinary sodium excretion rate at time point 1, uEq/min, mean±SD | 91.7±58.7 |
| Stress urinary sodium excretion rate at time point 2 uEq/min, mean±SD | 206.2±134.4 |
| Change in urinary sodium excretion rate with stress, uEq/min, mean±SD | 114.6±124.8 |
| Awake urinary sodium excretion rate, uEq/min, mean±SD | 84.9±43.5 |
| Asleep urinary sodium excretion rate, uEq/min, mean±SD | 83.4±78.5 |
| Awake‐to‐asleep ratio of urinary sodium excretion rate, unitless, mean±SD | 1.44±1.26 |
| Awake SBP, mm Hg, mean±SD | 116.6±10.5 |
| Awake DBP, mm Hg, mean±SD | 73.0±6.8 |
| Asleep SBP, mm Hg, mean±SD | 99.9±9.8 |
| Asleep DBP, mm Hg, mean±SD | 58.0±6.6 |
| SBP dipping, %, mean±SD | 14.0±6.3 |
| DBP dipping, %, mean±SD | 20.1±7.8 |
DBP indicates diastolic blood pressure; EMA, ecological momentary assessment; and SBP, systolic blood pressure.
Effects of the Mental Stress Tasks on VAS Stress Ratings, BP, and Heart Rate
From baseline (time point 1) to immediately after the mental stress tasks (time point 2), there was a statistically significant increase in VAS stress ratings (P<0.0001; Table S1), an effect that was no longer present after the recovery period (time point 3). There were also statistically significant increases in SBP, DBP, and heart rate immediately after the mental stress tasks (Table S2).
Association Between Urinary Sodium Excretion Rate With Stress in the Laboratory and Awake‐to‐Asleep Ratio of Urinary Sodium Excretion Over a 24‐Hour Period (Hypothesis 1)
Figure 3 shows a histogram of the change in urinary sodium excretion rate with stress in the laboratory. In an unadjusted model, a smaller change in urinary sodium excretion rate with stress in the laboratory was associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate over the subsequent 24‐hour period (B coefficient=0.3373 [95% CI, 0.1578–0.5167]; P=0.0003; Table 2). In a model that adjusted for age, sex, race, ethnicity, and BMI (model 1), a smaller change in urinary sodium excretion rate with stress in the laboratory also was associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate over a 24‐hour period (B coefficient=0.2601 [95% CI, 0.0855–0.4347]; P=0.0037). In a model that further adjusted for mean SBP during the baseline period, mean DBP during the baseline period, parental history of hypertension, fasting glucose, and 24‐hour creatinine clearance (model 2), a smaller change in urinary sodium excretion rate with stress in the laboratory was associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate during the next 24 hours (Table 2).
Figure 3. Histogram of the change in urinary sodium excretion rate with stress in the laboratory.

Sample size is 180 participants.
Table 2.
Association Between Change in Urinary Sodium Excretion Rate With Stress (uEq/min) and Awake‐to‐Asleep Ratio of Urinary Sodium Excretion Rate (Unitless)
| Model | Rescaled B coefficient (95% CI) | P value |
|---|---|---|
| Unadjusted |
0.3373 (0.1578–0.5167) |
0.0003 |
| Model 1 |
0.2601 (0.0855–0.4347) |
0.0037 |
| Model 2 |
0.2253 (0.0490–0.4016) |
0.0126 |
Sample size is 180 participants. Rescaled B coefficients represent the effect of a 1‐SD change in urinary sodium excretion rate with stress. One SD of change in urinary sodium excretion rate with stress is 124.7784 uEq/min. Model 1 includes age, sex, race, ethnicity, and body mass index as covariates. Model 2 includes model 1 covariates plus mean systolic blood pressure during the baseline period, mean diastolic blood pressure during the baseline period, parental history of hypertension, fasting glucose, and 24‐hour creatinine clearance.
In a fully adjusted model, mean EMA ratings of perceived stress did not moderate the association between the urinary sodium excretion rate with stress in the laboratory and awake‐to‐asleep ratio of urinary sodium excretion over a 24‐hour period (interaction term was not statistically significant; Table S3). Similarly, mean EMA ratings of angry/hostile, aggravated/irritated, anxious/tense/nervous, and sad/blue/depressed also did not moderate this association.
Association Between Awake‐to‐Asleep Ratio of Urinary Sodium Excretion Rate Over a 24‐Hour Period and BP Dipping Over a 24‐Hour Period (Hypothesis 2)
In an unadjusted model, a lower awake‐to‐asleep ratio of urinary sodium excretion rate over a 24‐hour period was associated with lower SBP dipping (B coefficient=0.9807 [95% CI, 0.0923–1.8691]; P=0.0307; Table 3). This association remained statistically significant in adjusted models (models 1–4). In unadjusted and adjusted models, awake‐to‐asleep ratio of urinary sodium excretion over a 24‐hour period was not associated with DBP dipping (Table 3).
Table 3.
Association Between Awake‐to‐Asleep Ratio of Urinary Sodium Excretion Rate (Unitless) and Blood Pressure Dipping (%)
| Model | Rescaled B coefficients (95% CI) | P value |
|---|---|---|
| Systolic blood pressure dipping | ||
| Unadjusted |
0.9807 (0.0923 to 1.8691) |
0.0307 |
| Model 1 |
0.9670 (0.0458 to 1.8882) |
0.0398 |
| Model 2 |
1.0427 (0.1203 to 1.9651) |
0.0270 |
| Model 3 |
1.0209 (0.0718 to 1.9700) |
0.0352 |
| Model 4 |
1.0127 (0.0599 to 1.9656) |
0.0374 |
| Diastolic blood pressure dipping | ||
| Unadjusted |
0.9403 (−0.2037 to 2.0843) |
0.1066 |
| Model 1 |
0.8006 (−0.4116 to 2.0128) |
0.1941 |
| Model 2 |
0.8232 (−0.3967 to 2.0431) |
0.1845 |
| Model 3 |
0.7470 (−0.4997 to 1.9937) |
0.2384 |
| Model 4 |
0.7451 (−0.5071 to 1.9973) |
0.2416 |
Sample size is 175 participants. Rescaled B coefficients represent the effect of a 1‐SD change in awake‐to‐asleep ratio of urinary sodium excretion rate. One SD change in awake‐to‐asleep ratio of urinary sodium excretion rate (unitless) is 1.2285. Model 1 includes age, sex, race, and ethnicity as covariates. Model 2 includes model 1 covariates plus body mass index, current smoking, alcohol use (none, moderate, heavy), and fasting blood glucose. Model 3 includes model 2 covariates plus 24‐hour sodium excretion, 24‐hour potassium excretion, and 24‐hour creatinine clearance. Model 4 includes model 3 covariates plus fractional excretion of sodium.
Exploratory Analyses
Interactions by Sex
In a fully adjusted model, there was no evidence that sex moderated the associations between either change in urinary sodium excretion rate with stress and awake‐to‐asleep ratio of urinary sodium excretion rate (interaction P=0.4086) or awake‐to‐asleep ratio of urinary sodium excretion rate and BP dipping (interaction P=0.5418 for SBP dipping and interaction P=0.4097 for DBP dipping).
Associations of BP Reactivity With Awake‐to‐Asleep Ratio of Urinary Sodium Excretion Rate and BP Dipping
A greater increase from baseline to peak SBP and DBP with the mental stress tasks was associated with a higher awake‐to‐asleep ratio of urinary sodium excretion rate (r=0.1806, P=0.0156 for SBP; and r=0.1835, P=0.0142 for DBP). Neither the increase from baseline to peak SBP nor the increase from baseline to peak DBP was associated with BP dipping (r=0.0324, P=0.6712 for SBP dipping; and r=0.0294, P=0.7006 for DBP dipping).
Associations Between the Change in Urinary Sodium Excretion Rate With Stress and Awake Urinary Sodium Excretion Rate, and Separately, Asleep Urinary Sodium Excretion Rate
In a fully adjusted model, a smaller change in urinary sodium excretion rate with stress was associated with a lower awake urinary sodium excretion rate (Table S4). There was no association between the change in urinary sodium excretion rate with stress and asleep urinary sodium excretion rate (Table S5).
EMA Ratings of Perceived Stress and the Change in Urinary Sodium Excretion Rate With Stress as Moderators of the Association Between Awake‐to‐Asleep Ratio of Urinary Sodium Excretion Rate and BP Dipping
There was no evidence that either EMA ratings of perceived stress during the ambulatory session (Table S6) or change in urinary sodium excretion rate with stress during the laboratory session (Table S7) moderated the association of the awake‐to‐asleep ratio of urinary sodium excretion rate with either SBP dipping or DBP dipping.
Association Between the Change in Urinary Sodium Excretion Rate With Stress and BP Dipping
In unadjusted and adjusted models (models 1–4), a smaller change in urinary sodium excretion rate with stress was associated with lower SBP and DBP dipping (Table S8). For SBP dipping, the addition of the awake‐to‐asleep ratio of urinary sodium excretion rate reduced the B coefficient from 1.3397 (model 4) to 1.1860 (model 5), representing an 11.5% attenuation of the association between the change in urinary sodium excretion rate with stress and SBP dipping. For DBP dipping, the addition of the awake‐to‐asleep ratio of urinary sodium excretion rate reduced the B coefficient from 2.0371 to 2.0001, representing a 1.8% attenuation.
DISCUSSION
It has been proposed that lower stress‐induced urinary sodium excretion is linked to the development of hypertension in humans. 28 , 29 , 30 The SABRE study confirmed our primary hypotheses that among apparently healthy adults, a smaller urinary sodium excretion rate with stress in the laboratory is associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate over a 24‐hour period, which in turn is associated with lower SBP dipping.
Prior studies have demonstrated that salt sensitivity contributes to an altered circadian pattern of sodium excretion and reduced BP dipping. 23 , 53 , 54 , 55 These studies were conducted primarily in individuals with established hypertension and classified participants as having salt‐sensitive or salt‐resistant hypertension on the basis of BP responses to controlled high‐ and low‐sodium diets. In addition, several of these studies did not directly assess the awake‐to‐asleep ratio of urinary sodium excretion rate by measuring sodium excretion separately during awake and asleep periods. 53 , 54 , 55 Our findings extend this conceptual framework by suggesting that lower stress‐induced sodium excretion, a pathway distinct from salt sensitivity, may be associated with a lower awake‐to‐asleep ratio of urinary sodium excretion and reduced SBP dipping. Importantly, the SABRE study was not designed to evaluate salt sensitivity, and therefore, participants did not receive high‐ and low‐sodium diets. Rather, participants consumed standardized diets to minimize variation in sodium and potassium intake and thereby isolate individual differences in sodium handling. This design addressed a key limitation of prior studies examining either stress‐induced sodium excretion, or the association between diurnal patterns of sodium excretion and BP, many of which did not control for dietary sodium or potassium intake. 22 , 43 , 48 , 49 , 50 , 52 , 56 , 57 , 58 , 59 , 60 , 61 Prior evidence suggests that high versus low sodium intake does not reduce BP dipping among individuals without hypertension, 62 , 63 implying that the link between salt sensitivity and reduced BP dipping may be mainly expressed among individuals who have hypertension. Our study enrolled young adults without established hypertension, further suggesting that salt sensitivity is unlikely to have an impact on our study findings.
In the SABRE study, the association between the urinary sodium excretion rate with stress in the laboratory and awake‐to‐asleep ratio of urinary sodium excretion rate over a 24‐hour period was not stronger among individuals with higher EMA levels of stress during the awake period. Also, there was no evidence that EMA levels of stress moderated the association between awake‐to‐asleep ratio of urinary sodium excretion rate and BP dipping. However, the study was not powered to examine a statistical interaction of EMA stress level on these associations. Acute stress in the laboratory setting induced by mental stress tasks, which was used to measure stress‐induced sodium excretion, is not synonymous with ecological stress. 64 , 65 These null findings could reflect differences between the acute psychological stress induced in the laboratory and the stressors, both acute and chronic, encountered in daily life. Further, self‐reported perceived stress and physiological stress responses represent related but distinct aspects of the stress response and often demonstrate only modest correlations. 66 , 67 Thus, EMA‐assessed perceived stress may not capture the physiological processes reflected by stress‐induced sodium excretion. Future studies should examine the extent to which ecological stress contributes to the associations among stress‐induced sodium excretion, the awake‐to‐asleep ratio of the urinary sodium excretion rate, and BP dipping.
We observed that greater BP reactivity to stress was associated with a higher awake‐to‐asleep ratio of the urinary sodium excretion rate. These findings may indicate that a more robust physiological response to acute stress, reflected by both greater BP reactivity and higher sodium excretion rate with stress, is associated with a more favorable diurnal pattern of sodium excretion. Rather than suggesting that larger stress responses are inherently beneficial, the findings may reflect greater physiological regulatory capacity, whereas blunted responses could indicate a less adaptive state associated with impaired sodium handling across the 24‐hour cycle. However, these results should be interpreted cautiously because the analyses were exploratory, and BP reactivity was not associated with BP dipping, suggesting that the role of BP reactivity is unclear.
The results also do not support the alternative explanation that individuals with lower stress‐induced sodium excretion have lower sodium excretion throughout the entire 24‐hour period as a smaller change in the urinary sodium excretion rate with stress was associated with a lower awake but not asleep urinary sodium excretion rate. Therefore, individuals with lower stress‐induced sodium excretion may have a reduced ability to excrete sodium during the awake period, resulting in a lower awake‐to‐asleep urinary sodium excretion ratio and reduced BP dipping.
The awake‐to‐asleep ratio of the urinary sodium excretion rate partially explained the association between the change in the urinary sodium excretion rate with stress and SBP dipping. Although these findings provide support for the hypothesized pathway linking stress‐induced sodium excretion, the diurnal pattern of sodium excretion, and BP dipping, they do not establish a causal biological mechanism. Future studies examining whether interventions that target stress responses or sodium handling influence diurnal sodium excretion and BP dipping are warranted.
The findings of the current study indicate that a 1‐SD decrease in the awake‐to‐asleep ratio of the urinary sodium excretion rate was associated with a 1.01‐percentage‐point lower SBP dipping. Although modest in magnitude, a 1‐percentage‐point difference in SBP dipping has been associated with differences in cardiovascular risk in prior cohort studies. 68 , 69 The sample was young and apparently healthy without comorbidities including CVD risk factors or prevalent CVD. Further, participants taking antihypertensive medication were excluded. It is unclear whether the findings of our study are generalizable to older adults with comorbidities, including those with hypertension or those taking antihypertensive medication. Therefore, the clinical implications of reduced BP dipping in this population may differ from those in older and higher‐risk populations in whom reduced BP dipping is more prevalent and its prognostic significance is better established. 70 Whether the association between the awake‐to‐asleep ratio of the urinary sodium excretion rate and SBP dipping becomes more pronounced over time as individuals age, accumulate cardiovascular risk factors, and take cardiovascular medications, and whether such progression contributes to greater cardiovascular risk remain unclear. Consistent with this framework, a prior study found that the association between the awake‐to‐asleep ratio of the urinary sodium excretion rate and SBP dipping was evident only among adults aged >50 years and was not observed among those aged ≤50 years. 71 Future studies should determine whether the associations observed in the current study are also present or are more pronounced in older adults and individuals with hypertension or other cardiovascular risk factors.
Finally, although sex did not modify the associations examined in the current study, prior studies have reported that there may be sex differences in stress‐induced pressure natriuresis, including differences in the magnitude of stress‐induced sodium excretion and in its association with adiposity. 43 , 52 Future adequately powered studies should examine whether the associations among psychological stress, urinary sodium excretion and its diurnal pattern, and BP dipping differ between men and women.
The study has several strengths. The study was conducted both in the laboratory setting and in the naturalistic environment in the same participants, which is a unique feature of the study. The study examined diurnal patterns of both sodium excretion and BP over a 24‐hour period, moving beyond the traditional paradigm of conducting measures only during the awake period. The inclusion of stress‐induced sodium excretion, the diurnal pattern of sodium excretion, and BP dipping, together within 1 conceptual framework, is also unique. Finally, the study included a community sample of adults with excellent representation of women and notable racial and ethnic diversity.
There are also several potential limitations. The study did not include a neutral condition in the laboratory session as a control. However, the purpose of this study was not to determine whether an exposure to an acute stressor using a mental stress task would increase urinary sodium excretion when compared with a neutral condition. Consistent with prior studies, we defined stress‐induced sodium excretion as the change in urinary sodium excretion after provoked stress compared with a resting baseline, allowing for each person's resting baseline to serve as their own control. 28 , 29 , 30 , 42 , 43 , 48 , 49 , 50 , 52 , 58 , 59 , 60 Participants were instructed to maintain their usual diets during the ambulatory session. This approach was chosen to maximize the feasibility of the study protocol, which required participants to undergo 24‐hour ABPM, collect urine separately during awake and asleep periods, complete a device log, and also respond to Qualtrics surveys delivered via SMS text messages at random time points throughout the awake period. Only one 24‐hour ABPM period was assessed. However, prior studies have demonstrated that lower BP dipping assessed over a single 24‐hour ABPM period is associated with an increased risk of CVD events. 4 , 5 In addition, urinary sodium excretion was assessed from a single 24‐hour urine collection. The purpose of this measurement was not to estimate habitual sodium intake, but rather to quantify urinary sodium excretion during the same 24‐hour period in which BP was measured by ABPM. Although multiple nonconsecutive 24‐hour urine collections have been recommended for estimating usual sodium intake because of day‐to‐day variability in sodium excretion, 72 , 73 combining repeated urine collections with repeated ABPM periods would not have been feasible in this study. Although individuals with moderate to severe sleep apnea and chronic insomnia were excluded from the study, it is possible that some of the participants had mild sleep apnea or other types of sleep disturbance including short and long sleep duration that affect BP. 74 Further, it is possible that sleep was disturbed due to repeated cuff‐based BP measurements on ABPM. Therefore, the study cannot completely exclude sleep disturbances as a contributing factor. Approximately 22% to 23% of the participants did not have a high‐quality urine collection. This is consistent with prior published studies 37 , 41 and indicates the challenges with successfully collecting urine over a 24‐hour period for enrolled participants. Finally, stress‐induced sodium excretion may have a genetic basis, and individual differences in this response appear to be partially heritable. 60 , 75 While available data support moderate reproducibility of stress‐induced sodium excretion when classified as sodium retention versus nonretention, 28 its test–retest reliability as a continuous measure has not been well characterized. Therefore, additional studies are needed to establish the stability of stress‐induced sodium excretion as an individual‐level biomarker.
In summary, in the SABRE study, a smaller change in urinary sodium excretion rate with stress in the laboratory was associated with a lower awake‐to‐asleep ratio of urinary sodium excretion rate over a 24‐hour period, and a lower ratio of awake‐to‐asleep urinary sodium excretion rate was associated with lower BP dipping over the same 24‐hour period. These findings provide support for the hypothesized pathway linking stress‐induced sodium excretion, the diurnal pattern of sodium excretion, and BP dipping. Our clinical and translational study lays the groundwork for future mechanistic studies examining the biological link between stress‐induced sodium excretion and the diurnal patterns of sodium excretion and BP.
Sources of Funding
This work was supported by the National Institutes of Health (R01 HL137818) from the National Heart, Lung, and Blood Institute. The National Institutes of Health/National Heart, Lung, and Blood Institute had no role in analyzing the data or preparing the results, and the views expressed here do not necessarily represent those of the funding agency.
Disclosures
None.
Supporting information
Data S1
Tables S1–S8
Figure S1
This article was sent to Yen‐Hung Lin, MD, PhD, Associate Editor, for review by expert referees, editorial decision, and final disposition.
Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.126.050471
For Sources of Funding and Disclosures, see page 12.
References
- 1. Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, Myers MG, Ogedegbe G, Schwartz JE, Townsend RR, et al. Measurement of blood pressure in humans: a scientific statement from the american heart association. Hypertension. 2019;73:e35–e66. doi: 10.1161/HYP.0000000000000087 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Gumz ML, Shimbo D, Abdalla M, Balijepalli RC, Benedict C, Chen Y, Earnest DJ, Gamble KL, Garrison SR, Gong MC, et al. Toward precision medicine: circadian rhythm of blood pressure and chronotherapy for hypertension ‐ 2021 NHLBI workshop report. Hypertension. 2023;80:503–522. doi: 10.1161/HYPERTENSIONAHA.122.19372 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163:691–700. doi: 10.7326/M15-1270 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Gavriilaki M, Anyfanti P, Nikolaidou B, Lazaridis A, Gavriilaki E, Douma S, Gkaliagkousi E. Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: a systematic review and meta‐analysis. J Clin Hypertens (Greenwich). 2020;22:1951–1959. doi: 10.1111/jch.14039 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Taylor KS, Heneghan CJ, Stevens RJ, Adams EC, Nunan D, Ward A. Heterogeneity of prognostic studies of 24‐hour blood pressure variability: systematic review and meta‐analysis. PLoS One. 2015;10:e0126375. doi: 10.1371/journal.pone.0126375 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Abdalla M, Goldsmith J, Muntner P, Diaz KM, Reynolds K, Schwartz JE, Shimbo D. Is isolated nocturnal hypertension a reproducible phenotype? Am J Hypertens. 2016;29:33–38. doi: 10.1093/ajh/hpv058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Blunted sleep‐time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non‐dipper” paradox. Chronobiol Int. 2013;30:87–98. doi: 10.3109/07420528.2012.701127 [DOI] [PubMed] [Google Scholar]
- 8. Spruill TM, Shallcross AJ, Ogedegbe G, Chaplin WF, Butler M, Palfrey A, Shimbo D, Muntner P, Sims M, Sarpong DF, et al. Psychosocial correlates of nocturnal blood pressure dipping in african americans: the Jackson Heart Study. Am J Hypertens. 2016;29:904–912. doi: 10.1093/ajh/hpw008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Bello NA, Jaeger BC, Booth JN 3rd, Abdalla M, Anstey DE, Pugliese DN, Lewis CE, Gidding SS, Lloyd‐Jones D, Shah SJ, et al. Associations of awake and asleep blood pressure and blood pressure dipping with abnormalities of cardiac structure: the coronary artery risk development in young adults study. J Hypertens. 2020;38:102–110. doi: 10.1097/HJH.0000000000002221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Cohen S, Janicki‐Deverts D, Miller GE. Psychological stress and disease. JAMA. 2007;298:1685–1687. doi: 10.1001/jama.298.14.1685 [DOI] [PubMed] [Google Scholar]
- 11. Clays E, Van Herck K, De Buyzere M, Kornitzer M, Kittel F, De Backer G, De Bacquer D. Behavioural and psychosocial correlates of nondipping blood pressure pattern among middle‐aged men and women at work. J Hum Hypertens. 2012;26:381–387. doi: 10.1038/jhh.2011.42 [DOI] [PubMed] [Google Scholar]
- 12. Huang Y, Mai W, Hu Y, Wu Y, Song Y, Qiu R, Dong Y, Kuang J. Poor sleep quality, stress status, and sympathetic nervous system activation in nondipping hypertension. Blood Press Monit. 2011;16:117–123. doi: 10.1097/MBP.0b013e328346a8b4 [DOI] [PubMed] [Google Scholar]
- 13. Mellman TA, Brown DD, Jenifer ES, Hipolito MM, Randall OS. Posttraumatic stress disorder and nocturnal blood pressure dipping in young adult african americans. Psychosom Med. 2009;71:627–630. doi: 10.1097/psy.0b013e3181a54341 [DOI] [PubMed] [Google Scholar]
- 14. Steffen PR, McNeilly M, Anderson N, Sherwood A. Effects of perceived racism and anger inhibition on ambulatory blood pressure in african americans. Psychosom Med. 2003;65:746–750. doi: 10.1097/01.PSY.0000079380.95903.78 [DOI] [PubMed] [Google Scholar]
- 15. Thomas KS, Nelesen RA, Dimsdale JE. Relationships between hostility, anger expression, and blood pressure dipping in an ethnically diverse sample. Psychosom Med. 2004;66:298–304. doi: 10.1097/01.psy.0000126196.82317.9d [DOI] [PubMed] [Google Scholar]
- 16. Ulmer CS, Calhoun PS, Bosworth HB, Dennis MF, Beckham JC. Nocturnal blood pressure non‐dipping, posttraumatic stress disorder, and sleep quality in women. Behav Med. 2013;39:111–121. doi: 10.1080/08964289.2013.813434 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Neubert M, Sussenbach P, Euteneuer F. Subjective social status and nocturnal blood pressure dipping. J Psychosom Res. 2022;163:111065. doi: 10.1016/j.jpsychores.2022.111065 [DOI] [PubMed] [Google Scholar]
- 18. Huang Y, Mai W, Cai X, Hu Y, Song Y, Qiu R, Wu Y, Kuang J. The effect of zolpidem on sleep quality, stress status, and nondipping hypertension. Sleep Med. 2012;13:263–268. doi: 10.1016/j.sleep.2011.07.016 [DOI] [PubMed] [Google Scholar]
- 19. Mellman TA, Brown TS, Kobayashi I, Abu‐Bader SH, Lavela J, Altaee D, McLaughlin L, Randall OS. Blood pressure dipping and urban stressors in young adult african americans. Ann Behav Med. 2015;49:622–627. doi: 10.1007/s12160-014-9684-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension. 2006;48:527–533. doi: 10.1161/01.HYP.0000240268.37379.7c [DOI] [PubMed] [Google Scholar]
- 21. Huart J, Persu A, Lengele JP, Krzesinski JM, Jouret F, Stergiou GS. Pathophysiology of the nondipping blood pressure pattern. Hypertension. 2023;80:719–729. doi: 10.1161/HYPERTENSIONAHA.122.19996 [DOI] [PubMed] [Google Scholar]
- 22. Bankir L, Bochud M, Maillard M, Bovet P, Gabriel A, Burnier M. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in african subjects. Hypertension. 2008;51:891–898. doi: 10.1161/HYPERTENSIONAHA.107.105510 [DOI] [PubMed] [Google Scholar]
- 23. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis. 1999;33:29–35. doi: 10.1016/S0272-6386(99)70254-4 [DOI] [PubMed] [Google Scholar]
- 24. Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. Dipper and non‐dipper blood pressure 24‐hour patterns: circadian rhythm‐dependent physiologic and pathophysiologic mechanisms. Chronobiol Int. 2013;30:17–30. doi: 10.3109/07420528.2012.715872 [DOI] [PubMed] [Google Scholar]
- 25. Coleman TG, Manning RD Jr, Norman RA Jr, Granger HJ, Guyton AC. The role of salt in experimental and human hypertension. Am J Med Sci. 1972;264:103–110. doi: 10.1097/00000441-197208000-00002 [DOI] [PubMed] [Google Scholar]
- 26. Hall JE, Guyton AC, Coleman TG, Mizelle HL, Woods LL. Regulation of arterial pressure: role of pressure natriuresis and diuresis. Fed Proc. 1986;45:2897–2903. [PubMed] [Google Scholar]
- 27. Ivy JR, Bailey MA. Pressure natriuresis and the renal control of arterial blood pressure. J Physiol. 2014;592:3955–3967. doi: 10.1113/jphysiol.2014.271676 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Harshfield GA, Dong Y, Kapuku GK, Zhu H, Hanevold CD. Stress‐induced sodium retention and hypertension: a review and hypothesis. Curr Hypertens Rep. 2009;11:29–34. doi: 10.1007/s11906-009-0007-8 [DOI] [PubMed] [Google Scholar]
- 29. Light KC, Turner JR. Stress‐induced changes in the rate of sodium excretion in healthy black and white men. J Psychosom Res. 1992;36:497–508. doi: 10.1016/0022-3999(92)90011-P [DOI] [PubMed] [Google Scholar]
- 30. Rollnik JD, Mills PJ, Dimsdale JE. Characteristics of individuals who excrete versus retain sodium under stress. J Psychosom Res. 1995;39:499–505. doi: 10.1016/0022-3999(95)00045-K [DOI] [PubMed] [Google Scholar]
- 31. Dong M, McGoldrick MT, Seid H, Cohen LP, LaRocca A, Pham P, Thomas SJ, Schwartz JE, Shimbo D. The stress, salt excretion, and nighttime blood pressure (SABRE) study: rationale and study design. Am Heart J Plus. 2022;13:100099. doi: 10.1016/j.ahjo.2022.100099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Sateia MJ. International classification of sleep disorders‐third edition: highlights and modifications. Chest. 2014;146:1387–1394. doi: 10.1378/chest.14-0970 [DOI] [PubMed] [Google Scholar]
- 33. Hu JR, Sahni S, Mukamal KJ, Millar CL, Wu Y, Appel LJ, Juraschek SP. Dietary sodium intake and sodium density in the United States: estimates from NHANES 2005‐2006 and 2015‐2016. Am J Hypertens. 2020;33:825–830. doi: 10.1093/ajh/hpaa104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Quader ZS, Zhao L, Gillespie C, Cogswell ME, Terry AL, Moshfegh A, Rhodes D. Sodium intake among persons aged >/=2 years ‐ United States, 2013‐2014. MMWR Morb Mortal Wkly Rep. 2017;66:324–328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. de Greeff A, Shennan AH. Validation of the spacelabs 90227 ontrak device according to the european and british hypertension societies as well as the american protocols. Blood Press Monit. 2020;25:110–114. doi: 10.1097/MBP.0000000000000424 [DOI] [PubMed] [Google Scholar]
- 36. Booth JN 3rd, Muntner P, Abdalla M, Diaz KM, Viera AJ, Reynolds K, Schwartz JE, Shimbo D. Differences in night‐time and daytime ambulatory blood pressure when diurnal periods are defined by self‐report, fixed‐times, and actigraphy: improving the detection of hypertension study. J Hypertens. 2016;34:235–243. doi: 10.1097/HJH.0000000000000791 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Terry AL, Cogswell ME, Wang CY, Chen TC, Loria CM, Wright JD, Zhang X, Lacher DA, Merritt RK, Bowman BA. Feasibility of collecting 24‐h urine to monitor sodium intake in the national health and nutrition examination survey. Am J Clin Nutr. 2016;104:480–488. doi: 10.3945/ajcn.115.121954 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Wang CY, Cogswell ME, Loria CM, Chen TC, Pfeiffer CM, Swanson CA, Caldwell KL, Perrine CG, Carriquiry AL, Liu K, et al. Urinary excretion of sodium, potassium, and chloride, but not iodine, varies by timing of collection in a 24‐hour calibration study. J Nutr. 2013;143:1276–1282. doi: 10.3945/jn.113.175927 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Du X, Fang L, Guo J, Chen X, Su S, Zhang J. Validity of predictive equations for 24‐h urinary sodium excretion at the population and individual levels among chinese adults aged 18‐69 years. Sci Rep. 2021;11:22404. doi: 10.1038/s41598-021-00513-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Jackson SL, Cogswell ME, Zhao L, Terry AL, Wang CY, Wright J, Coleman King SM, Bowman B, Chen TC, Merritt R, et al. Association between urinary sodium and potassium excretion and blood pressure among adults in the United States: national health and nutrition examination survey, 2014. Circulation. 2018;137:237–246. doi: 10.1161/CIRCULATIONAHA.117.029193 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Cogswell ME, Loria CM, Terry AL, Zhao L, Wang CY, Chen TC, Wright JD, Pfeiffer CM, Merritt R, Moy CS, et al. Estimated 24‐hour urinary sodium and potassium excretion in us adults. JAMA. 2018;319:1209–1220. doi: 10.1001/jama.2018.1156 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Harshfield GA, Wilson ME, Hanevold C, Kapuku GK, Mackey L, Gillis D, Treiber FA. Impaired stress‐induced pressure natriuresis increases cardiovascular load in african american youths. Am J Hypertens. 2002;15:903–906. doi: 10.1016/s0895-7061(02)02994-1 [DOI] [PubMed] [Google Scholar]
- 43. Harshfield GA, Wilson ME, McLeod K, Hanevold C, Kapuku GK, Mackey L, Gillis D, Edmonds L. Adiposity is related to gender differences in impaired stress‐induced pressure natriuresis. Hypertension. 2003;42:1082–1086. doi: 10.1161/01.HYP.0000100424.84889.F7 [DOI] [PubMed] [Google Scholar]
- 44. Booth JN 3rd, Muntner P, Diaz KM, Viera AJ, Bello NA, Schwartz JE, Shimbo D. Evaluation of criteria to detect masked hypertension. J Clin Hypertens (Greenwich). 2016;18:1086–1094. doi: 10.1111/jch.12830 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Viera AJ, Zhu S, Hinderliter AL, Shimbo D, Person SD, Jacobs DR Jr. Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults: the CARDIA study. J Am Soc Hypertens. 2011;5:48–55. doi: 10.1016/j.jash.2010.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Yang WY, Thijs L, Zhang ZY, Asayama K, Boggia J, Hansen TW, Ohkubo T, Jeppesen J, Stolarz‐Skrzypek K, Malyutina S, et al. Evidence‐based proposal for the number of ambulatory readings required for assessing blood pressure level in research settings: an analysis of the IDACO database. Blood Press. 2018;27:341–350. doi: 10.1080/08037051.2018.1476057 [DOI] [PubMed] [Google Scholar]
- 47. Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, Colantonio LD. Trends in blood pressure control among us adults with hypertension, 1999‐2000 to 2017‐2018. JAMA. 2020;324:1190–1200. doi: 10.1001/jama.2020.14545 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Wilson ME, Harshfield GA, Ortiz L, Hanevold C, Kapuka G, Mackey L, Gillis D, Edmonds L, Evans C. Relationship of body composition to stress‐induced pressure natriuresis in youth. Am J Hypertens. 2004;17:1023–1028. doi: 10.1016/j.amjhyper.2004.05.007 [DOI] [PubMed] [Google Scholar]
- 49. Light KC, Koepke JP, Obrist PA, Willis PW 4th. Psychological stress induces sodium and fluid retention in men at high risk for hypertension. Science. 1983;220:429–431. doi: 10.1126/science.6836285 [DOI] [PubMed] [Google Scholar]
- 50. Schneider MP, Klingbeil AU, Schlaich MP, Langenfeld MR, Veelken R, Schmieder RE. Impaired sodium excretion during mental stress in mild essential hypertension. Hypertension. 2001;37:923–927. doi: 10.1161/01.HYP.37.3.923 [DOI] [PubMed] [Google Scholar]
- 51. Ayala DE, Moya A, Crespo JJ, Castineira C, Dominguez‐Sardina M, Gomara S, Sineiro E, Mojon A, Fontao MJ, Hermida RC, et al. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 2013;30:99–115. [DOI] [PubMed] [Google Scholar]
- 52. Harshfield GA, Hanevold C, Kapuku GK, Dong Y, Castles ME, Ludwig DA. The association of race and sex to the pressure natriuresis response to stress. Ethn Dis. 2007;17:498–502. [PubMed] [Google Scholar]
- 53. Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1997;96:1859–1862. doi: 10.1161/01.CIR.96.6.1859 [DOI] [PubMed] [Google Scholar]
- 54. Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Determinants of circadian blood pressure rhythm in essential hypertension. Am J Hypertens. 1999;12:35–39. doi: 10.1016/s0895-7061(98)00182-4 [DOI] [PubMed] [Google Scholar]
- 55. Higashi Y, Oshima T, Ozono R, Nakano Y, Matsuura H, Kambe M, Kajiyama G. Nocturnal decline in blood pressure is attenuated by NaCl loading in salt‐sensitive patients with essential hypertension: noninvasive 24‐hour ambulatory blood pressure monitoring. Hypertension. 1997;30:163–167. doi: 10.1161/01.HYP.30.2.163 [DOI] [PubMed] [Google Scholar]
- 56. Ducher M, Bertram D, Pozet N, Laville M, Fauvel JP. Stress‐induced renal alterations in normotensives offspring of hypertensives and in hypertensives. Am J Hypertens. 2002;15:346–350. doi: 10.1016/S0895-7061(01)02333-0 [DOI] [PubMed] [Google Scholar]
- 57. Fauvel JP, Hadj‐Aissa A, Laville M, Daoud S, Labeeuw M, Pozet N, Zech P. Stress‐induced renal functional alterations in normotensives. Am J Hypertens. 1991;4:955–958. doi: 10.1093/ajh/4.12.955 [DOI] [PubMed] [Google Scholar]
- 58. Harshfield GA, Pulliam DA, Alpert BS. Patterns of sodium excretion during sympathetic nervous system arousal. Hypertension. 1991;17:1156–1160. doi: 10.1161/01.HYP.17.6.1156 [DOI] [PubMed] [Google Scholar]
- 59. Harshfield GA, Treiber FA, Davis H, Kapuku GK. Impaired stress‐induced pressure natriuresis is related to left ventricle structure in blacks. Hypertension. 2002;39:844–847. doi: 10.1161/01.HYP.0000013735.85681.74 [DOI] [PubMed] [Google Scholar]
- 60. Ge D, Su S, Zhu H, Dong Y, Wang X, Harshfield GA, Treiber FA, Snieder H. Stress‐induced sodium excretion: a new intermediate phenotype to study the early genetic etiology of hypertension? Hypertension. 2009;53:262–269. doi: 10.1161/HYPERTENSIONAHA.108.118117 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Staessen JA, Birkenhager W, Bulpitt CJ, Fagard R, Fletcher AE, Lijnen P, Thijs L, Amery A. The relationship between blood pressure and sodium and potassium excretion during the day and at night. J Hypertens. 1993;11:443–447. doi: 10.1097/00004872-199304000-00016 [DOI] [PubMed] [Google Scholar]
- 62. Brian MS, Dalpiaz A, Matthews EL, Lennon‐Edwards S, Edwards DG, Farquhar WB. Dietary sodium and nocturnal blood pressure dipping in normotensive men and women. J Hum Hypertens. 2017;31:145–150. doi: 10.1038/jhh.2016.53 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Simonetti GD, Farese S, Aregger F, Uehlinger D, Frey FJ, Mohaupt MG. Nocturnal dipping behaviour in normotensive white children and young adults in response to changes in salt intake. J Hypertens. 2010;28:1027–1033. doi: 10.1097/HJH.0b013e328337854d [DOI] [PubMed] [Google Scholar]
- 64. Kamarck TW, Schwartz JE, Janicki DL, Shiffman S, Raynor DA. Correspondence between laboratory and ambulatory measures of cardiovascular reactivity: a multilevel modeling approach. Psychophysiology. 2003;40:675–683. doi: 10.1111/1469-8986.00069 [DOI] [PubMed] [Google Scholar]
- 65. Zanstra YJ, Johnston DW. Cardiovascular reactivity in real life settings: measurement, mechanisms and meaning. Biol Psychol. 2011;86:98–105. doi: 10.1016/j.biopsycho.2010.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Campbell J, Ehlert U. Acute psychosocial stress: does the emotional stress response correspond with physiological responses? Psychoneuroendocrinology. 2012;37:1111–1134. doi: 10.1016/j.psyneuen.2011.12.010 [DOI] [PubMed] [Google Scholar]
- 67. Vaessen T, Rintala A, Otsabryk N, Viechtbauer W, Wampers M, Claes S, Myin‐Germeys I. The association between self‐reported stress and cardiovascular measures in daily life: a systematic review. PLoS One. 2021;16:e0259557. doi: 10.1371/journal.pone.0259557 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, Abe H, Katsuya T, Fujita Y, Okazaki O, et al. Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner‐based nationwide JAMP study. Circulation. 2020;142:1810–1820. doi: 10.1161/CIRCULATIONAHA.120.049730 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24‐h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183–2189. doi: 10.1097/00004872-200211000-00017 [DOI] [PubMed] [Google Scholar]
- 70. Parati G, Pengo MF, Avolio A, Azizi M, Bothe TL, Burnier M, Cappuccio FP, Sierra A, Fava C, Gironacci MM, et al. Nocturnal blood pressure: pathophysiology, measurement and clinical implications. Position paper of the european society of hypertension. J Hypertens. 2025;43:1296–1318. doi: 10.1097/HJH.0000000000004053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Del Giorno R, Troiani C, Gabutti S, Stefanelli K, Puggelli S, Gabutti L. Impaired daytime urinary sodium excretion impacts nighttime blood pressure and nocturnal dipping at older ages in the general population. Nutrients. 2020;12. doi: 10.3390/nu12072013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Campbell NRC, He FJ, Tan M, Cappuccio FP, Neal B, Woodward M, Cogswell ME, McLean R, Arcand J, MacGregor G, et al. The international consortium for quality research on dietary sodium/salt (TRUE) position statement on the use of 24‐hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake. J Clin Hypertens (Greenwich). 2019;21:700–709. doi: 10.1111/jch.13551 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Lerchl K, Rakova N, Dahlmann A, Rauh M, Goller U, Basner M, Dinges DF, Beck L, Agureev A, Larina I, et al. Agreement between 24‐hour salt ingestion and sodium excretion in a controlled environment. Hypertension. 2015;66:850–857. doi: 10.1161/HYPERTENSIONAHA.115.05851 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Makarem N, Alcantara C, Williams N, Bello NA, Abdalla M. Effect of sleep disturbances on blood pressure. Hypertension. 2021;77:1036–1046. doi: 10.1161/HYPERTENSIONAHA.120.14479 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Zhu H, Lu Y, Wang X, Snieder H, Treiber FA, Harshfield GA, Dong Y. The g protein‐coupled receptor kinase 4 gene modulates stress‐induced sodium excretion in black normotensive adolescents. Pediatr Res. 2006;60:440–442. doi: 10.1203/01.pdr.0000238250.64591.44 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data S1
Tables S1–S8
Figure S1
